1309443-99-9,MFCD18712598
Catalog No.:AA01CBYI

1309443-99-9 | 2,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
97%
2 weeks  
$265.00   $186.00
- +
100mg
97%
2 weeks  
$420.00   $294.00
- +
250mg
97%
2 weeks  
$684.00   $479.00
- +
1g
97%
2 weeks  
$1,710.00   $1,197.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01CBYI
Chemical Name:
2,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine
CAS Number:
1309443-99-9
Molecular Formula:
C13H20BNO2
Molecular Weight:
233.1144
MDL Number:
MFCD18712598
SMILES:
Cc1ncc(c(c1)B1OC(C(O1)(C)C)(C)C)C
Properties
Computed Properties
 
Complexity:
277  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  

Downstream Synthesis Route

[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2011/64288,2011,A1Locationinpatent:Page/Pagecolumn31

[2]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2012/238561,2012,A1Locationinpatent:Page/Pagecolumn12

[3]Sadler,ScottA.;Tajuddin,Hazmi;Mkhalid,IbraheemA.I.;Batsanov,AndreiS.;Albesa-Jove,David;Cheung,ManSing;Maxwell,AoifeC.;Shukla,Lena;Roberts,Bryan;Blakemore,DavidC.;Lin,Zhenyang;Marder,ToddB.;Steel,PatrickG.[OrganicandBiomolecularChemistry,2014,vol.12,#37,p.7318-7327]

[4]CurrentPatentAssignee:BAYERAG-WO2019/81343,2019,A1Locationinpatent:Page/Pagecolumn108

[1]CurrentPatentAssignee:DIZAL(JIANGSU)PHARMACEUTICALCO.,LTD.-WO2020/52631,2020,A1Locationinpatent:Page/Pagecolumn78

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:1309443-99-9 Molecular Formula|1309443-99-9 MDL|1309443-99-9 SMILES|1309443-99-9 2,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine
Catalog No.: AA01CBYI
1309443-99-9,MFCD18712598
1309443-99-9 | 2,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine
Pack Size: 50mg
Purity: 97%
2 weeks
$265.00 $186.00
Pack Size: 100mg
Purity: 97%
2 weeks
$420.00 $294.00
Pack Size: 250mg
Purity: 97%
2 weeks
$684.00 $479.00
Pack Size: 1g
Purity: 97%
2 weeks
$1,710.00 $1,197.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01CBYI
Chemical Name: 2,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine
CAS Number: 1309443-99-9
Molecular Formula: C13H20BNO2
Molecular Weight: 233.1144
MDL Number: MFCD18712598
SMILES: Cc1ncc(c(c1)B1OC(C(O1)(C)C)(C)C)C
Properties
Complexity: 277  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 17  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
Downstream Synthesis Route
589-93-5    73183-34-3    1309443-99-9 

[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2011/64288,2011,A1Locationinpatent:Page/Pagecolumn31

[2]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2012/238561,2012,A1Locationinpatent:Page/Pagecolumn12

[3]Sadler,ScottA.;Tajuddin,Hazmi;Mkhalid,IbraheemA.I.;Batsanov,AndreiS.;Albesa-Jove,David;Cheung,ManSing;Maxwell,AoifeC.;Shukla,Lena;Roberts,Bryan;Blakemore,DavidC.;Lin,Zhenyang;Marder,ToddB.;Steel,PatrickG.[OrganicandBiomolecularChemistry,2014,vol.12,#37,p.7318-7327]

[4]CurrentPatentAssignee:BAYERAG-WO2019/81343,2019,A1Locationinpatent:Page/Pagecolumn108

17117-23-6    73183-34-3    1309443-99-9 

[1]CurrentPatentAssignee:DIZAL(JIANGSU)PHARMACEUTICALCO.,LTD.-WO2020/52631,2020,A1Locationinpatent:Page/Pagecolumn78

Building Blocks More >
431898-95-2
431898-95-2
b-D-Glucopyranoside, phenylmethyl4-O-(3-O-sulfo-b-D-galactopyranosyl)-, monosodium salt
AA01CC1X
959119-26-7
959119-26-7
Erythromycin-13C,d3
AA01CC5F | MFCD09842676
466-06-8
466-06-8
Bufa-4,20,22-trienolide,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-14-hydroxy-, (3b)-
AA01CC8G | MFCD00214065
83413-07-4
83413-07-4
2-Methylimidazole-d3
AA01CCC5
957055-11-7
957055-11-7
β-Caryophyllinic Acid
AA01CCEZ
1794898-13-7
1794898-13-7
Tetrahydro Curcumin-d6
AA01CCIW
503068-35-7
503068-35-7
1,3-Benzenedimethanol,a1-[[[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexyl]amino]methyl]-4-hydroxy-, (a1R)-, acetate (salt)
AA01CCN0
911372-79-7
911372-79-7
(S)-6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride
AA01D91Y | MFCD22393199
1320346-97-1
1320346-97-1
Glpg0187
AA01DDQM | MFCD31381920
909390-59-6
909390-59-6
1-Methyl-3-(4-sulfobutyl)imidazolium Bis(trifluoromethanesulfonyl)imide
AA01DFB1 | MFCD12761444
Submit
© 2017 AA BLOCKS, INC. All rights reserved.